The short answer
Do not self-add 5-HTP to phenelzine. This combination can cause serious adverse effects, and a published case describes mania after 5-HTP was added. That case did not establish serotonin syndrome, so the two outcomes should not be presented as the same finding.
What this answer covers
Oral L-5-hydroxytryptophan supplements with oral phenelzine. This does not equate 5-HTP with L-tryptophan or every botanical product containing a precursor.
- Supplement or preparation
- L-5-HTP
- Medication ingredient
- phenelzine
Why 5-HTP is relevant
5-HTP is converted to serotonin. Phenelzine reduces monoamine breakdown, making added serotonergic substances a concern. Its availability as a supplement does not remove the need for the same interaction review as a medicine.
What the actual case described
A man receiving phenelzine developed mania after adding 5-HTP. He had other possible contributors, including a steroid taper. The author favored drug-induced mania and specifically noted the absence of the additional signs needed to diagnose serotonin syndrome in this patient.
Mania and serotonin toxicity are different
Markedly reduced need for sleep, unusually driven or erratic behavior and escalating mood need prompt clinical attention. Fever, confusion and muscle rigidity or jerking can point to a different urgent toxicity syndrome. A label should not collapse these into one outcome.
Changing the time is not a solution
No safe co-use dose or spacing schedule was established. Contact the prescriber before using 5-HTP, and do not stop or taper phenelzine on your own. Severe or rapidly worsening symptoms warrant urgent assessment.
Evidence and practical considerations
Side effects & toxicity
NARDIL contraindicates serotonergic agents. A direct case supports a possible mood-destabilizing effect after 5-HTP addition, with competing contributors. Serotonin-syndrome risk remains a pharmacologic warning rather than the confirmed diagnosis in that case.
- Exact scope
- Oral L-5-hydroxytryptophan supplements with oral phenelzine. This does not equate 5-HTP with L-tryptophan or every botanical product containing a precursor. with Oral phenelzine tablets; current sulfate-tablet labeling uses the named active ingredient.
- Medication form and route
- oral
What remains uncertain
- Single confounded case; prednisone and other psychiatric medicines complicate attribution. No exact-pair event rate or safe dose was established.
Factors that may matter: Exact supplement preparation and complete concomitant-medication list require assessment..
Read the supporting source summaries
Source 1: Current U.S. prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral phenelzine sulfate tablets.
The label prohibits sympathomimetics, L-tryptophan, L-tyrosine, phenylalanine and serotonergic agents. It warns about excessive caffeine and high-tyramine exposures.
How this applies: Primary authority for phenelzine oral-tablet precautions; each article identifies whether the supplement is named or the application is a constituent/class inference.
Regulatory instructions do not quantify an exact-pair event rate or validate every botanical formulation.
Source 2: Human case report
pmc.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: One 60-year-old man with treatment-resistant depression, asthma and several concomitant medicines.
Mania developed after addition of 5-HTP. The author favored drug-induced mania; hyperreflexia occurred without the other clinical signs needed to establish serotonin syndrome in this case.
How this applies: Direct phenelzine plus L-5-HTP coexposure supporting a mood-destabilization concern, while not proving the discovery claim of serotonin syndrome.
Single case with prednisone exposure, phenelzine and other psychiatric medicines as alternative or contributing explanations. It is not confirmed serotonin syndrome.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Initial targeted research draft. Inspected source material, adjudicated the current checker statements, and recorded preparation limits. Clinical review has not occurred. | |
| Research summary published |
Article revision: 546c9aa2864867df
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.